Invivyd Inc. (NASDAQ:IVVD) announced that new in vitro neutralization data show continued neutralizing activity of Pemgarda ...
Challenge trials help researchers study immune responses. Skeptics still doubt the approach is worth the risks ...
The COVID-19 pandemic, it turned out, had almost as big a gastronomical effect on American society as government actions.
Speculation about the alleged findings of a study on long COVID and post-vaccination syndrome spread widely among vaccine ...
After a relatively slow start to the respiratory virus season, Covid-19 levels in the United States began ramping up just ...
From carbon emissions to the share price of videoconferencing firm Zoom, these graphs tell the story of how the covid-19 ...
If you’ve been hit with a respiratory tract infection this festive season, it’s more likely to be Covid-19 than the flu.
The world first became aware of Covid-19 five years ago. We evaluate where we are, remember how we got here, and consider ...
In 2023, the WHO estimated that the real death toll of the pandemic was at least 20 million Covid-19: over 7 million deaths ...
Federal funding for COVID-19 vaccines will stop this year and the provinces and territories will be responsible for buying ...
Another year has gone by since the 2020 pandemic and COVID-19 remains at large, so experts weigh in on what will change in 2025.
The latest confirmed hospitalization data shows notable increases of more than 30% in hospital admissions due to both ...